Cresset Asset Management’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.82M | Buy |
16,972
+3,081
| +22% | +$331K | 0.01% | 582 |
|
2025
Q1 | $1.4M | Sell |
13,891
-1,559
| -10% | -$157K | 0.01% | 645 |
|
2024
Q4 | $1.38M | Sell |
15,450
-88,821
| -85% | -$7.93M | 0.01% | 661 |
|
2024
Q3 | $8.74M | Buy |
104,271
+4,309
| +4% | +$361K | 0.03% | 337 |
|
2024
Q2 | $7.7M | Buy |
99,962
+12,543
| +14% | +$966K | 0.03% | 334 |
|
2024
Q1 | $5.99M | Buy |
87,419
+11,419
| +15% | +$782K | 0.03% | 349 |
|
2023
Q4 | $4.39M | Buy |
76,000
+4,722
| +7% | +$273K | 0.03% | 368 |
|
2023
Q3 | $3.76M | Buy |
71,278
+7,389
| +12% | +$390K | 0.01% | 367 |
|
2023
Q2 | $3.46M | Buy |
63,889
+41,994
| +192% | +$2.27M | ﹤0.01% | 377 |
|
2023
Q1 | $1.1M | Buy |
21,895
+504
| +2% | +$25.2K | 0.02% | 330 |
|
2022
Q4 | $937K | Buy |
+21,391
| New | +$937K | 0.01% | 312 |
|
2022
Q2 | – | Sell |
-11,317
| Closed | -$501K | – | 962 |
|
2022
Q1 | $501K | Buy |
11,317
+2,268
| +25% | +$100K | 0.01% | 607 |
|
2021
Q4 | $385K | Buy |
9,049
+1,345
| +17% | +$57.2K | ﹤0.01% | 788 |
|
2021
Q3 | $335K | Buy |
7,704
+1,397
| +22% | +$60.7K | ﹤0.01% | 797 |
|
2021
Q2 | $270K | Sell |
6,307
-3,781
| -37% | -$162K | ﹤0.01% | 827 |
|
2021
Q1 | $390K | Buy |
+10,088
| New | +$390K | 0.01% | 559 |
|
2020
Q4 | – | Sell |
-5,544
| Closed | -$212K | – | 777 |
|
2020
Q3 | $212K | Sell |
5,544
-3,813
| -41% | -$146K | ﹤0.01% | 624 |
|
2020
Q2 | $329K | Buy |
9,357
+1,731
| +23% | +$60.9K | 0.01% | 432 |
|
2020
Q1 | $249K | Buy |
7,626
+96
| +1% | +$3.14K | 0.01% | 450 |
|
2019
Q4 | $341K | Buy |
7,530
+844
| +13% | +$38.2K | 0.01% | 384 |
|
2019
Q3 | $272K | Buy |
+6,686
| New | +$272K | 0.01% | 413 |
|
2019
Q2 | – | Sell |
-3,508
| Closed | -$135K | – | 643 |
|
2019
Q1 | $135K | Sell |
3,508
-333
| -9% | -$12.8K | 0.01% | 471 |
|
2018
Q4 | $136K | Buy |
+3,841
| New | +$136K | 0.01% | 268 |
|